Last reviewed · How we verify
Qingpeng Ointment
Qingpeng Ointment is a Small molecule drug developed by Guangzhou University of Traditional Chinese Medicine. It is currently FDA-approved.
Qingpeng Ointment is a treatment used in a clinical study for shoulder syndrome during the rehabilitation period of cerebral hemorrhage. The exact mechanism of Qingpeng Ointment is unknown.
At a glance
| Generic name | Qingpeng Ointment |
|---|---|
| Sponsor | Guangzhou University of Traditional Chinese Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Qingpeng Ointment CI brief — competitive landscape report
- Qingpeng Ointment updates RSS · CI watch RSS
- Guangzhou University of Traditional Chinese Medicine portfolio CI
Frequently asked questions about Qingpeng Ointment
What is Qingpeng Ointment?
Who makes Qingpeng Ointment?
What development phase is Qingpeng Ointment in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing